HRMY

HRMY

USD

Harmony Biosciences Holdings Inc. Common Stock

$30.720+1.470 (5.026%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$29.250

Hoch

$30.890

Tief

$27.660

Volumen

1.44M

Unternehmensfundamentaldaten

Marktkapitalisierung

1.8B

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.82M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $25.52Aktuell $30.720Hoch $40.93

Ähnliche Nachrichten

BusinessWire

Harmony Biosciences Reports Strong Q3 2025 Financial Results; Recently Raised 2025 Revenue Guidance to $845-$865M

WAKIX® (pitolisant) Franchise Delivers Net Revenue of $239M in Q3 2025 (+29% YoY Growth) Record Increase in Average Number of Patients of Approximately 500 to Achieve 8,100 Average Patients in Q3 2025 Strong Cash

Mehr anzeigen
Harmony Biosciences Reports Strong Q3 2025 Financial Results; Recently Raised 2025 Revenue Guidance to $845-$865M
BusinessWire

Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) today announced preliminary results for Q3 2025, highlighted by the following: WAKIX® (pitolisant) franchise delivered net revenue of approximately $239M in Q3

Mehr anzeigen
Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance